Sofiva Genomics Co.,Ltd. (TPEX:6615)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.45
-1.00 (-2.67%)
Jun 25, 2026, 1:30 PM CST
Market Cap787.08M +8.6%
Revenue (ttm)382.82M -10.6%
Net Income8.39M +211.1%
EPS0.39 +210.3%
Shares Out 21.59M
PE Ratio93.83
Forward PEn/a
Dividend0.30 (0.82%)
Ex-Dividend DateJun 27, 2025
Volume33,027
Open37.50
Previous Close37.45
Day's Range36.40 - 37.50
52-Week Range28.90 - 40.00
Beta0.21
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About Sofiva Genomics

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessm... [Read more]

Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6615
Full Company Profile

Financial Performance

Financial Statements